OmniAb, Inc. (OABI)
2.035
-0.12
(-5.35%)
USD |
NASDAQ |
Dec 15, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
OmniAb Total Liabilities (Quarterly): 32.25M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 216.26M |
| GT Biopharma, Inc. | 1.321M |
| Karyopharm Therapeutics, Inc. | 365.49M |
| Zevra Therapeutics, Inc. | 136.95M |
| Foghorn Therapeutics, Inc. | 294.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 309.69M |
| Shareholders Equity (Quarterly) | 277.44M |
| Debt to Equity Ratio | 0.0759 |
| Current Ratio | 4.997 |
| Net Debt Paydown Yield | 0.28% |